• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠中 VEGF-D 缺乏并不影响胚胎期或出生后的淋巴管生成,但会减少淋巴转移。

VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.

机构信息

Vesalius Research Centre, VIB, B-3000 Leuven, Belgium.

出版信息

J Pathol. 2009 Nov;219(3):356-64. doi: 10.1002/path.2605.

DOI:10.1002/path.2605
PMID:19718705
Abstract

Vascular endothelial growth factor-D (VEGF-D) is one of the two ligands of the VEGFR-3 receptor on lymphatic endothelial cells. Gene-silencing studies in mice and Xenopus tadpoles recently showed that the role of endogenous VEGF-D in lymphatic development is moderate. By contrast, exogenous VEGF-D is capable of stimulating lymphangiogenesis. Nonetheless, its endogenous role in pathological conditions remains largely unknown. Hence, we reassessed its role in disease, using Vegf-d(null) mice. Vegf-d(null) mice were generated that, under physiological conditions, displayed normal embryonic and postnatal lymphangiogenesis and lymphatic remodelling, efficient lymphatic functioning and normal health. Vegf-d(null) mice also reponded normally in models of skin wound healing and healing of infarcted myocardium, despite enhanced expression of VEGF-D in these models in wild-type mice. In contrast, Vegf-d(null) mice displayed reduced peritumoral lymphangiogenesis and lymph node metastasis in an orthotopic pancreatic tumour model. Together, our data indicate that endogenous VEGF-D in mice is dispensible for lymphangiogenesis during development, in postnatal and adult physiology and in several pathological conditions, but significantly contributes to lymphatic metastasis.

摘要

血管内皮生长因子-D(VEGF-D)是淋巴管内皮细胞上 VEGFR-3 受体的两个配体之一。最近在小鼠和非洲爪蟾幼体中的基因沉默研究表明,内源性 VEGF-D 在淋巴管发育中的作用是适度的。相比之下,外源性 VEGF-D 能够刺激淋巴管生成。然而,其在病理性条件下的内源性作用在很大程度上仍然未知。因此,我们使用 Vegf-d(null) 小鼠重新评估了其在疾病中的作用。生成了 Vegf-d(null) 小鼠,在生理条件下,它们显示出正常的胚胎和出生后淋巴管生成和淋巴管重塑、有效的淋巴管功能和正常的健康状况。在皮肤伤口愈合和梗死心肌愈合的模型中,尽管野生型小鼠中这些模型中 VEGF-D 的表达增强,但 Vegf-d(null) 小鼠也正常应答。相比之下,在原位胰腺肿瘤模型中,Vegf-d(null) 小鼠显示出肿瘤周围淋巴管生成和淋巴结转移减少。总之,我们的数据表明,内源性 VEGF-D 在小鼠中对于发育过程中的淋巴管生成、出生后和成年生理以及几种病理性条件是可有可无的,但对淋巴管转移有显著贡献。

相似文献

1
VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.在小鼠中 VEGF-D 缺乏并不影响胚胎期或出生后的淋巴管生成,但会减少淋巴转移。
J Pathol. 2009 Nov;219(3):356-64. doi: 10.1002/path.2605.
2
Vascular endothelial growth factor D is dispensable for development of the lymphatic system.血管内皮生长因子D对淋巴系统的发育并非必需。
Mol Cell Biol. 2005 Mar;25(6):2441-9. doi: 10.1128/MCB.25.6.2441-2449.2005.
3
Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.淋巴管生成及其在恶性黑色素瘤中与淋巴转移和预后的关系。
Anat Rec (Hoboken). 2008 Oct;291(10):1227-35. doi: 10.1002/ar.20736.
4
Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.胰腺导管腺癌的淋巴转移独立于淋巴管生成。
J Pathol. 2005 Nov;207(3):301-12. doi: 10.1002/path.1840.
5
Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.血管内皮生长因子-D在胰腺导管癌模型中诱导淋巴管生成和淋巴转移。
Int J Oncol. 2005 Sep;27(3):669-79.
6
Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.神经细胞黏附分子的缺失通过上调淋巴管生成诱导肿瘤转移。
Cancer Res. 2004 Dec 1;64(23):8630-8. doi: 10.1158/0008-5472.CAN-04-2523.
7
Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.血管内皮生长因子-a促进肿瘤周围淋巴管生成和淋巴转移。
Cancer Res. 2005 Oct 15;65(20):9261-8. doi: 10.1158/0008-5472.CAN-04-2345.
8
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.血管内皮生长因子A、B、C和D在肺腺癌中的表达及其与淋巴结状态的关系。
Clin Cancer Res. 2000 Jun;6(6):2431-9.
9
Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.肿瘤分泌的血管内皮生长因子-C对前列腺癌淋巴管生成是必需的,但淋巴管生成对淋巴结转移并非必需。
Cancer Res. 2005 Nov 1;65(21):9789-98. doi: 10.1158/0008-5472.CAN-05-0901.
10
[The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].[高、低转移潜能小鼠肝癌中淋巴管生成与淋巴转移的关系]
Zhonghua Gan Zang Bing Za Zhi. 2006 Mar;14(3):187-91.

引用本文的文献

1
Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.超越血管:揭示血管内皮生长因子对神经元功能和结构的影响
J Biomed Sci. 2025 Mar 6;32(1):33. doi: 10.1186/s12929-025-01128-8.
2
Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?血管内皮生长因子(VEGF)家族与免疫系统:激活剂还是抑制剂?
Biomedicines. 2024 Dec 24;13(1):6. doi: 10.3390/biomedicines13010006.
3
Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma.
S-亚硝基化抑制 VEGFD 表达促进肺腺癌的发展。
J Exp Clin Cancer Res. 2022 Aug 8;41(1):239. doi: 10.1186/s13046-022-02453-8.
4
Targeting angiogenesis and lymphangiogenesis in kidney disease.靶向肾脏疾病中的血管生成和淋巴管生成。
Nat Rev Nephrol. 2020 May;16(5):289-303. doi: 10.1038/s41581-020-0260-2. Epub 2020 Mar 6.
5
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.一石二鸟:双重打击肿瘤生长和淋巴管生成通过靶向血管内皮生长因子受体 3。
Cells. 2019 Mar 21;8(3):270. doi: 10.3390/cells8030270.
6
Growth and Immune Evasion of Lymph Node Metastasis.淋巴结转移的生长与免疫逃逸
Front Oncol. 2018 Feb 21;8:36. doi: 10.3389/fonc.2018.00036. eCollection 2018.
7
Emerging Roles for VEGF-D in Human Disease.VEGF-D 在人类疾病中的新作用。
Biomolecules. 2018 Jan 4;8(1):1. doi: 10.3390/biom8010001.
8
Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors.血管内皮生长因子D升高调节肿瘤炎症并减少致癌物诱导的皮肤肿瘤生长。
Neoplasia. 2016 Jul;18(7):436-46. doi: 10.1016/j.neo.2016.05.002.
9
Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.在胰腺癌模型中,联合靶向转化生长因子-β(TGF-β)、表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)可抑制淋巴管生成和转移。
Cancer Lett. 2016 Aug 28;379(1):143-53. doi: 10.1016/j.canlet.2016.05.037. Epub 2016 Jun 3.
10
Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.蛋白水解激活作用定义了VEGFC和VEGFD不同的淋巴管生成机制。
J Clin Invest. 2016 Jun 1;126(6):2167-80. doi: 10.1172/JCI83967. Epub 2016 May 9.